Becerra, E; De La Torre, I; Leandro, MJ; Cambridge, G; (2017) B cell phenotypes in patients with rheumatoid arthritis relapsing after rituximab: expression of B cell-activating factor-binding receptors on B cell subsets. Clinical and Experimental Immunology , 190 (3) pp. 372-383. 10.1111/cei.13024.

Preview	Text (Article) Cambridge_CEI-2017-6498R1 untrack changes CEI May 2017 BBRs.pdf - Accepted Version Download (329kB) | Preview
Preview	Image Cambridge_Slide1.jpg - Accepted Version Download (139kB) | Preview
Preview	Image Cambridge_Slide2.jpg - Accepted Version Download (94kB) | Preview
Preview	Image Cambridge__Slide3.jpg - Accepted Version Download (102kB) | Preview
Preview	Image Cambridge__Slide4.jpg - Accepted Version Download (102kB) | Preview
Preview	Image Cambridge_Slide5.jpg - Accepted Version Download (91kB) | Preview
Preview	Image Cambridge__Slide6.jpg - Accepted Version Download (71kB) | Preview

Abstract

Serum levels of B cell‐activating factor (BAFF) rise following rituximab (RTX) therapy in patients with rheumatoid arthritis (RA). Initiation of naive B cell return to the periphery and autoreactive B cell expansion leading to relapse after RTX may therefore be linked to interactions between BAFF and BAFF‐binding receptors (BBR). Relationships between serum BAFF and BBR expression [(BAFFR, calcium signal modulating cyclophilic ligand interactor (TACI) and B cell maturation antigen (BCMA)] were determined on B cell subsets, defined using immunoglobulin (Ig)D/CD38. Twenty pre‐RTX and 18 RA patients relapsing after B cell depletion were included. Results were analysed with respect to timing of relapse up to 7 months after peripheral B cell return (≥ 5 B cells/μl) and to serum BAFF levels. After B cell return, B cell populations from relapsing patients had significantly lower BAFFR+ expression compared to HC and pre‐RTX patients. The percentage of BAFFR+ B cells increased with time after B cell return and was correlated inversely with serum BAFF levels. BAFFR expression remained reduced. The percentage of TACI+ memory B cells were lower in RA patients after RTX compared with healthy controls (HC). BCMA expression (% and expression) did not differ between patients and HC. Relapse following B cell return appeared largely independent of the percentage of BAFFR+ or percentage of BCMA+ B cells or serum BAFF levels. The lower percentage of TACI+ memory B cells may reduce inhibitory signalling for B cell differentiation. In patients relapsing at longer periods after B cell return, recovery of the B cell pool was more complete, suggesting that selection or expansion of autoreactive B cells may be needed to precipitate relapse.

Download activity - last month

Export as JSONCSVXML

Download activity - last 12 months

Export as XMLCSVJSON

Downloads by country - last 12 months

Export as XMLCSVJSON

Archive Staff Only

View Item